Richard Scott Blackley - 02 Jun 2026 Form 4 Insider Report for Oscar Health, Inc. (OSCR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
04 Jun 2026, 16:15:56 UTC
Prior SEC filing
20 May 2026
Next SEC filing
18 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Melissa Curtin, Attorney-in-fact

Key filing fact

Richard Scott Blackley filed Form 4 for Oscar Health, Inc. (OSCR) on 04 Jun 2026.

Key facts

  • This page summarizes Richard Scott Blackley's Form 4 filing for Oscar Health, Inc. (OSCR).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Jun 2026, 16:15.

Change

  • Previous filing in this sequence was filed on 20 May 2026.
  • Current net transaction value: -$695,162.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001525020 Primary reporting owner

Blackley Richard Scott

Relationship
Chief Financial Officer
Address
75 VARICK STREET, 5TH FLOOR, NEW YORK
Signature
/s/ Melissa Curtin, Attorney-in-fact
Signature date
04 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OSCR transaction

Class A Common Stock

Sale

Transaction value
$493,628
Shares
-22,706
Change %
-2.1%
Price
$21.74
Shares after
1,083,954
Date
02 Jun 2026
Ownership
Direct
Footnotes
F1, F2, F3
OSCR transaction

Class A Common Stock

Sale

Transaction value
$201,534
Shares
-8,977
Change %
-0.83%
Price
$22.45
Shares after
1,074,977
Date
02 Jun 2026
Ownership
Direct
Footnotes
F1, F3, F4
OSCR holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
75,000
Date
02 Jun 2026
Ownership
By MQB Irrevocable Trust
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.03 to $22.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Footnote F3

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.03 to $22.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .